FDA Inspection 770786 — Carter BloodCare
The FDA completed an inspection of Carter BloodCare on Mar 5, 2012 in Rockwall, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 5, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rockwall, TX (United States)